Company intelligence / Profile preview
Changchun Institute of Biological Products Co., Ltd.
Changchun City, Jilin Province, 中国（China）gojilin.gov.cn ↗
- Ownership
- Private
- Employees
- ~900
- Development stage
- Commercial
01
Overview
CCIBP has a long track record as one of China’s leading vaccine manufacturers. Its quadrivalent influenza vaccine has been marketed for over two decades with more than 90 million doses sold and WHO prequalification achieved. The company also produces approved hepatitis A and rabies vaccines. It continues to develop new prophylactic vaccines targeting emerging infectious diseases such as tick-borne encephalitis and viral hemorrhagic fevers. Clinical trials are ongoing for next-generation influenza formulations and other indications.
- Therapeutic areas
- ImmunologyInfectious Diseases
- Modalities
- Prophylactic vaccinesinactivated vaccineslive attenuated vaccinesbiosimilarsinterferons
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
Request access →03
Partnerships
Parent company Sinopharm/CNBG provides extensive distribution channels domestically/internationallyInternational collaborations via WHO prequalification processes for global supply
Beyond the preview
Go deeper on Changchun Institute of Biological Products Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Changchun Institute of Biological Products Co., Ltd..